Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
Federica Frezzato, Flavia Raggi, Veronica Martini, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 11, pp. 3089-3100
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression
Chenglai Xia, Chang Liu, Zhihong He, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 51
Heat-Shock Proteins in Leukemia and Lymphoma: Multitargets for Innovative Therapeutic Approaches
Vincent Cabaud Gibouin, Manon Durand, Ronan Quéré, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 20
Mechanical manipulation of cancer cell tumorigenicity via heat shock protein signaling
Siu Hong Dexter Wong, Bohan Yin, Zhuo Li, et al.
Science Advances (2023) Vol. 9, Iss. 27
Open Access | Times Cited: 17
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment
Filippo Severin, Federica Frezzato, Andrea Visentin, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1939-1939
Open Access | Times Cited: 44
HSF1 Alleviates Brain Injury by Inhibiting NLRP3-Induced Pyroptosis in a Sepsis Model
Yifu He, Xi‐min Hu, Md. Asaduzzaman Khan, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-14
Open Access | Times Cited: 15
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 604-604
Open Access | Times Cited: 13
Effects of Melatonin, GM-CSF, IGF-1, and LIF in Culture Media on Embryonic Development: Potential Benefits of Individualization
Jungwon Choi, Sung Woo Kim, Hee-Sun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 751-751
Open Access | Times Cited: 5
Sex, senescence, senolytics, and cognition
Thomas C. Foster, Ashok Kumar
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
The Multifaceted Role of HSF1 in Tumorigenesis
Milad J. Alasady, Marc L. Mendillo
Advances in experimental medicine and biology (2020), pp. 69-85
Open Access | Times Cited: 36
miR-30b-3p Inhibits Proliferation and Invasion of Hepatocellular Carcinoma Cells via Suppressing PI3K/Akt Pathway
Dongkai Gao, Zumo Zhou, Heqing Huang
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 35
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model
Filippo Severin, Andrea Urbani, Tatiana Varanita, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 22
A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response
Ji Young Kim, Tae-Min Cho, Jung Min Park, et al.
Oncogene (2022) Vol. 41, Iss. 23, pp. 3289-3297
Open Access | Times Cited: 21
Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor
Xiang Zhang, Lei Ying, Xiang Chen, et al.
Biochemical Pharmacology (2024) Vol. 223, pp. 116155-116155
Open Access | Times Cited: 3
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance
Andrea Visentin, Stefano Pravato, Francesca Castellani, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1562-1562
Open Access | Times Cited: 15
<p>Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia</p>
Andrea Visentin, Federica Frezzato, Filippo Severin, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 9679-9688
Open Access | Times Cited: 21
Insulin/IGF-1 signaling and heat stress differentially regulate HSF1 activities in germline development
Stacey L. Edwards, Purevsuren Erdenebat, Allison C. Morphis, et al.
Cell Reports (2021) Vol. 36, Iss. 9, pp. 109623-109623
Open Access | Times Cited: 19
Emerging anticancer potential and mechanisms of snake venom toxins: A review
Xijun Guo, Yuanfeng Fu, Junbo Peng, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131990-131990
Closed Access | Times Cited: 2
Specific Roles of HSP27 S15 Phosphorylation Augmenting the Nuclear Function of HER2 to Promote Trastuzumab Resistance
Soo‐Yeon Hwang, Seul-Ki Choi, Seung Hee Seo, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1540-1540
Open Access | Times Cited: 20
The Modes of Dysregulation of the Proto-Oncogene T-Cell Leukemia/Lymphoma 1A
Johanna Stachelscheid, Qu Jiang, Marco Herling
Cancers (2021) Vol. 13, Iss. 21, pp. 5455-5455
Open Access | Times Cited: 17
Proteasome regulators in pancreatic cancer
Nirosha J. Murugan, Ioannis A. Voutsadakis
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 1, pp. 38-54
Open Access | Times Cited: 11
The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro
Narjis Fatima, Yandong Shen, Kyle Crassini, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 5, pp. 585-597
Open Access | Times Cited: 1
How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia
Nayla Mouawad, Edoardo Ruggeri, Guido Capasso, et al.
Hematological Oncology (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 1
In vitro maturation in the presence of Leukemia Inhibitory Factor modulates gene and miRNA expression in bovine oocytes and embryos
Meritxell Vendrell-Flotats, Tania García‐Martínez, Iris Martínez‐Rodero, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Long Noncoding RNA NONHSAT079852.2 Contributes to GBM Recurrence by Functioning as a ceRNA for has-mir-10401-3p to Facilitate HSPA1A Upregulation
Ningning Zhao, Jiajie Zhang, Lili Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia
Federica Frezzato, Andrea Visentin, Filippo Severin, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5453-5453
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top